NEW YORK (GenomeWeb News) – Seegene said today that Health Canada has approved two of its multiplex diagnostic tests for respiratory infections.
 
Health Canada awarded Medical Device Licenses for the company’s PCR-based Seeplex RV5 Auto Capillary Electrophoresis Screening and RV12 Auto Capillary Electrophoresis Detection tests.
 
The Seeplex RV5 test detects influenza A, influenza B, and respiratory syncytial virus A/B, and screens for 11 viruses; while the RV12 test identifies 12 viruses individually.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.